Search by Drug Name or NDC
NDC 00069-2377-10 Comirnaty 0.042 mg/.418mL Details
Comirnaty 0.042 mg/.418mL
Comirnaty is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is RAXTOZINAMERAN.
Product Information
| NDC | 00069-2377 |
|---|---|
| Product ID | 0069-2377_a0e017dc-e076-48f3-9cb6-c2d3608b26f8 |
| Associated GPIs | |
| GCN Sequence Number | 085219 |
| GCN Sequence Number Description | COVID vac 23-24(12up)(raxt)/PF SYRINGE 30 MCG/0.3 INTRAMUSC |
| HIC3 | Z0L |
| HIC3 Description | COVID-19 VACCINES |
| GCN | 54642 |
| HICL Sequence Number | 049179 |
| HICL Sequence Number Description | COVID VAC 2023-24 (12 YR AND UP) XBB.1.5 (RAXTOZINAMERAN)/PF |
| Brand/Generic | Brand |
| Proprietary Name | Comirnaty |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | COVID-19 Vaccine, mRNA |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 0.042 |
| Active Ingredient Units | mg/.418mL |
| Substance Name | RAXTOZINAMERAN |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125742 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-2377-10 (00069237710)
| NDC Package Code | 0069-2377-10 |
|---|---|
| Billing NDC | 00069237710 |
| Package | 10 SYRINGE, GLASS in 1 CARTON (0069-2377-10) / .418 mL in 1 SYRINGE, GLASS (0069-2377-01) |
| Marketing Start Date | 2023-10-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |